Bevacizumab in neoadjuvant treatment for breast cancer
- PMID: 22533583
- DOI: 10.1056/NEJMc1202229
Bevacizumab in neoadjuvant treatment for breast cancer
Comment on
-
Fighting fire with fire: rekindling the bevacizumab debate.N Engl J Med. 2012 Jan 26;366(4):374-5. doi: 10.1056/NEJMe1113368. N Engl J Med. 2012. PMID: 22276827 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical